A cost-utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom

Authors:

Lee D, Porter J, Gladwell D, Brereton N and Nielsen SK.

Publication Type:

Journal Article

Publication Name:

Journal of medical economics

Citation:

Lee D, Porter J, Gladwell D, Brereton N and Nielsen SK. A cost-utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom. J Med Econ. 2014;17(4):233-47.


Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies